STAT’s Best Health Opinion Pieces of 2025

Life Sciences in Focus: Top 2025 Issues & Diverse Voices Shaping the Debate

A new analysis of the most-read “First Opinion” essays reveals the critical issues dominating the life sciences landscape in 2025 – from vaccine debates and healthcare costs to the promise and pitfalls of artificial intelligence – and highlights the surprising breadth of perspectives driving the conversation.

The year’s most engaging pieces, a mix of free and STAT+ exclusive content, demonstrate that complex topics are best understood through nuanced arguments and personal experiences, moving beyond simplistic “pro” or “con” framings. This collection offers a vital snapshot of the concerns and insights shaping the future of medicine, biotechnology, and public health.

A Chorus of Expertise

What stands out most is the remarkable diversity of authors contributing to these discussions. The voices represented aren’t limited to traditional medical professionals; they include a dentist from India, a first-year medical student, a recent medical school graduate, a Theranos whistleblower, biotech and pharmaceutical executives, a medical archivist, a nutrition science researcher, and numerous physicians. This broad spectrum of expertise underscores the interconnectedness of the challenges facing the life sciences.

Notably, one piece from 2023 continues to resonate with readers – a surprisingly popular query about dietary recommendations before a colonoscopy – demonstrating the enduring relevance of practical health information. Four additional essays published in 2024 further emphasize the lasting impact of these First Opinion contributions.

Key Themes Emerging in 2025

Several core themes consistently surfaced in the most-read essays. Health insurance costs and access to care remain a central concern, with multiple pieces dissecting the complexities of the system. One author described insurance practices as “‘rationing by inconvenience’,” highlighting how insurers often rely on customers not appealing claim denials. Another warned that proposed changes to the Public Service Loan Forgiveness program could severely impact new physicians.

The potential – and limitations – of artificial intelligence (AI) in biopharma also garnered significant attention. Experts questioned why AI isn’t transforming the industry as rapidly as anticipated, despite its promise. The ongoing debate surrounding vaccines continued to be a focal point, with a critical analysis debunking flawed research promoted by an ally of Robert F. Kennedy Jr.

Beyond these headline issues, the essays also tackled less-publicized but equally important topics, such as the declining use of cadavers in medical education and the need for a new approach to the biotech workforce, which is experiencing increasing volatility.

Selected Insights from the Top 20 Essays

Here’s a glimpse into the key arguments presented in the most-read First Opinion pieces:

Free Access:

• The Wellness Industry’s Hidden Costs: Andrea Love argues that the wellness industry is contributing to animal suffering, disease spread, and potentially the next pandemic.
• Fluoride Debate from a Global Perspective: A dentist from India, Mannat Tiwana, expressed shock at the ongoing debate over fluoride in the U.S.
• Uncomfortable Truths About Seed Oils: Jane Zhao, a nutrition science researcher, explores the link between seed oils and chronic illness.
• The Value of Anatomical Study: Nadir Al-Saidi laments the decline in the use of cadavers in medical school curricula.
• Threats to American Medicine: Ryan Nadelson identifies a new challenge posed by an unnamed insurance company.
• Systemic Failures in Healthcare: Elliott S. Fisher argues that blaming individual insurance companies overlooks the broader systemic issues.
• Impact on Future Physicians: Kaley Parchinski details the potential negative consequences of changes to the Public Service Loan Forgiveness program.
• Colonoscopy Prep Simplified: Benjamin Lebwohl presents evidence that a liquid-only diet before a colonoscopy is unnecessary.
• Political Interference in Science: Zachary Utz raises concerns about potential political interference with scientific research, referencing the Human Genome Project.
• The Dangers of Unregulated Wellness: Andrea Love’s piece highlights the potential for harm within the burgeoning wellness industry.

STAT+ Exclusive:

• Trump’s Executive Function: Geriatric physician Joanne Lynn offers a medical perspective on former President Trump’s cognitive abilities.
• Lessons from Theranos: Tyler Shultz, the Theranos whistleblower, shares insights into the ongoing actions of Elizabeth Holmes.
• Debunking Vaccine Misinformation: Jake Scott refutes a flawed study used to support anti-vaccine claims.
• Biotech Workforce Instability: Gairik Sachdeva details the increasing volatility within the biotech industry.
• Reimagining the Life Sciences: Noël Theodosiou and Yogi Hendlin propose a new approach to innovation in the life sciences.
• MyChart and Patient Experience: Seth Joseph draws parallels between the travel industry and the challenges facing hospitals implementing electronic health record systems like MyChart.
• AI’s Slow Adoption in Biopharma: Greg Meyers investigates the reasons behind the slower-than-expected adoption of AI in the biopharmaceutical sector.
• RFK Jr.’s Vaccine Stance: Jonathan M. Berman argues that Robert F. Kennedy Jr.’s claims about vaccines are inaccurate.
• Hospital Consolidation Concerns: Philanthropists Laura and John Arnold warn about the potential negative consequences of hospital consolidation.
• U.S. Contributions to Medicine: Kevin Gardner and Michael Kinch present surprising findings about the contributions of U.S. academic institutions to pharmaceutical innovation.

Looking Ahead to 2026

While predicting the future is inherently uncertain, the authors anticipate that many of these same themes will continue to dominate the conversation in 2026. First Opinion plans to continue providing a platform for diverse voices and fresh perspectives on the evolving landscape of life sciences. The platform encourages submissions from individuals with unique insights to share, offering a pathway to contribute to the ongoing dialogue.